0 results for 'Eli Lilly'
Inside Track: Will EEOC's Switch to Democratic Control Spur Lawsuit-Filing Spree?
Two Republican members of the commission say some cases that are failing to win a majority vote for filing are being administratively withdrawn so that they can be voted on again after Democrats gain control.EEOC Closes Fiscal Year With Lawsuit Barrage That May Signal New Aggressiveness
A budget increase and pending shift in the political makeup of the commission could signal more activity in fiscal 2023.Navigating the Murky Waters of the Hatch-Waxman 'Safe Harbor'
The boundaries surrounding the Hatch-Waxman safe harbor are not always clear. This article explores the statutes and recent case law surrounding the provision to shed some light on its contours.Litigators of the Week: Walden Macht & Haran Team Hits Eli Lilly With Whistleblower Verdict
The $61 million verdict that Dan Miller, Jonathan DeSantis and Derek Cohen landed in Chicago federal court last week stands to be trebled to more than $183 million under the False Claims Act.Inside Track: Want to Be a Remote GC? Window of Opportunity May Have Closed
"The snapback in wanting people to come back to the office is real, and it is interesting," said Mike Evers, an attorney recruiter.View more book results for the query "Eli Lilly"
Want to Be a Remote GC? Window of Opportunity May Have Closed
"The snapback in wanting people to come back to the office is real, and it is interesting," said Mike Evers, an attorney recruiter.'Early Warning' on Law Firm Profits: The Morning Minute
The news and analysis you need to start your day.Eli Lilly, Cummins Issue Warnings on Economic Consequences of Indiana's Abortion Law
"We are deeply concerned about how this law impacts our people and impedes our ability to attract and retain a diverse workforce in Indiana—concerns that we have voiced to legislators," Cummins stated.Ebert v. Illinois Casualty Co.
The Indiana Supreme Court ruled that a liquor liability exclusion unambiguously precluded any duty to defend a suit in which an injured motorist alleged that a bar had negligently allowed a customer to become inebriated.Big Names Brandished in Effort to Restore $1.2B Cancer Treatment Verdict
The Federal Circuit ruled that a patent on a CAR-T treatment did not meet patent law's written description requirement. Jones Day and Irell & Manella are arguing for Bristol-Myers Squibb that the Federal Circuit has added judicial requirements to the statute that are virtually impossible for life sciences companies to meet.